EVOFEM BIOSCIENC(EVFM) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update — Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter — — Evofem Advances Plans for Special Meeting of Stockholders to Approve the A&R Merger Agreement and Become a Wholly-owned Subsidiary of Aditxt — SAN DIEGO, CA, August 14, 2025 — Women's health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the thr ...